Burger W, Chemnitius JM, Kneissl GD, Rücker G Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med. 2005; 257:(5)399-414
Keeling D, Baglin T, Tait C Guidelines on oral anticoagulation with warfarin. Br J Haematol. 2011; 153:(3)311-324
Perry DJ, Noakes TJC, Helliwell PS Guidelines for the management of patients on oral anticoagulants requiring dental surgery. Br Dent J. 2007; 203:389-393
Scully C, Wolff A Oral surgery in patients on anticoagulant therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 94:57-64
North West Medicines Information Centre. Surgical management of the primary care dental patient on warfarin. www.nelm.nhs.uk
Gomez-Moreno G, Aguilar-Salvatierra A, Martin-Piedra MA Dabigatran and rivaroxaban, new oral anticoagulants, new approaches in Dentistry. J Clin Exp Dent. 2010; 2:(1)e14-18
Technology Appraisal guidance 157: Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults.London: NICE; 2008
Technology Appraisal guidance 249: Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation.London: NICE; 2012
Haemostasis part 2: medications that affect haemostasis Neal J McCormick Undrell J Moore John G Meechan Mohsen Norouzi Dental Update 2025 41:5, 395-405.
Authors
Neal JMcCormick
BDS(Lpool), MFDS RCPS(Glasg)
General Professional Trainee (GPT), Health Education North East
Post-operative haemorrhage is a recognized complication in dental practice. This may be more prevalent in patients taking anti-thrombotic medications. It is important that the dentist understands the mechanism of action of these drugs and how they may affect management of dental patients.
Clinical Relevance: Dental professionals must be aware of those medications affecting haemostasis and how they may impact on management. The emergence of different therapeutic regimens has increased the number of such drugs.
Article
For many years, warfarin has been the most commonly used oral anticoagulant in the United Kingdom; however, as a long term medication it has disadvantages. This has led to the introduction of a number of new anticoagulant regimens that can impact on dental practice. Other medications, such as aspirin, are also used regularly for their anti-thrombotic effect. A clear understanding of oral anticoagulant therapy and the indications for treatment provision or suitable referral is important.
Prescribed medications are used to reduce the risk of a thrombo-embolic event. A thrombus is most likely to occur within a damaged vessel or heart wall. The pathologist Rudolph Virchow adopted a triad of risk factors for thrombo-embolism (Figure 1). These include:
The prevention and treatment of thrombo-embolism is the main indication for anticoagulant use. Table 1 shows the most common examples.
Some consideration should be given to the action of the different therapies available. They can be split into 3 main categories according to their action:
Register now to continue reading
Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits: